SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007066
Filing Date
2022-05-04
Accepted
2022-05-04 16:32:59
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20220331x10q.htm   iXBRL 10-Q 1204431
2 EX-31.1 edit-20220331xex31d1.htm EX-31.1 15566
3 EX-31.2 edit-20220331xex31d2.htm EX-31.2 15018
4 EX-32.1 edit-20220331xex32d1.htm EX-32.1 10074
  Complete submission text file 0001558370-22-007066.txt   5017251

Data Files

Seq Description Document Type Size
5 EX-101.SCH edit-20220331.xsd EX-101.SCH 24401
6 EX-101.CAL edit-20220331_cal.xml EX-101.CAL 39464
7 EX-101.DEF edit-20220331_def.xml EX-101.DEF 117116
8 EX-101.LAB edit-20220331_lab.xml EX-101.LAB 297420
9 EX-101.PRE edit-20220331_pre.xml EX-101.PRE 205563
45 EXTRACTED XBRL INSTANCE DOCUMENT edit-20220331x10q_htm.xml XML 979005
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 22892046
SIC: 2836 Biological Products, (No Diagnostic Substances)